Erratum: American college of gastroenterology guidelines for colorectal cancer screening 2008 (The American Journal of Gastroenterology (2009) 104 (739-750) DOI:10.1038/ajg.2009.104);American college of gastroenterology guidelines for colorectal cancer screening 2008

American Journal of Gastroenterology

Volumn 104, Issue 3, 2009, Pages 739-750

  Rex, Douglas K ^a   Johnson, David A ^a   Anderson, Joseph C ^a   Schoenfeld, Phillip S ^a   Burke, Carol A ^a   Inadomi, John M ^a  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; MYOSIN HEAVY CHAIN;

ADENOMATOUS POLYP; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CIGARETTE SMOKING; COLON RESECTION; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTED TOMOGRAPHIC COLONOGRAPHY; FAMILY HISTORY; GENE MUTATION; GENETIC SCREENING; HUMAN; IMMUNOCHEMISTRY; MEDICAL SCHOOL; OBESITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SIGMOIDOSCOPY;

EID: 61949256316     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.265     Document Type: Erratum

References (133)

1. Guyatt G, Gutterman D, Baumann MH et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians Task Force. Chest 2006;129:174-81.
2. Rex DK, Johnson DA, Lieberman DA et al. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. Am J Gastroenterol 2000;95:868-77.
3. Davila RE, Rajan E, Baron TH et al. ASGE guideline: colorectal cancer screening and surveillance. Gastrointest Endosc 2006;63:546-57.
4. Colorectal Cancer Screening. NCCN Clinical Practice Guidelines in Oncology. http:\\www.nccn.org (V.2.2008).
5. Winawer S, Fletcher R, Miller L et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997;112:594-642.
6. Byers T, Levin B, Rothenberger D et al. American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997. American Cancer Society Detection and Treatment Advisory Group on Colorectal Cancer. CA: Cancer J Clin 1997;47:154-60.
7. Winawer S, Fletcher R, Rex D, et al. Gastrointestinal Consortium P. Color-ectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology 2003;124:544-60.
8. Levin B, Lieberman DA, McFarland B et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008;134:1570-95.
9. Inadomi J, Kuhn L, Vijan S et al. Adherence to competing colorectal cancer screening strategies. Am J Gastroenterol 2005;100:S387-8.
10. Griffith MJ, Lewis CL, Brenner AR et al. The effect of offering different numbers of colorectal cancer screening test options in a decision aid: a pilot randomized trial. BMC Med Inform Decis Mak 2008;8:4; Available at http://www.biomedcentral.com/1472-6947/8/4.
11. Boolchand V, Olds G, Singh J et al. Colorectal screening after polypectomy: a national survey study of primary care physicians. Ann Intern Med 2006;145:654-9.
12. Mysliwiec PA, Brown ML, Klabunde CN et al. Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy. Ann Intern Med 2004;141:264-71.
13. Burke C, Issa M, Chruch J. A nationwide survey of post-polypectomy surveillance colonoscopy: too many too soon!. Gastroenterology 2005;128:A566.
14. Robertson RH, Burkhardt JH, Powell MP et al. Trends in colon cancer screening procedures in the US Medicare and Tricare populations: 1999-2001. Prev Med 2006;42:460-2.
15. Nakajima M, Saito H, Soma Y et al. Prevention of advanced colorectal cancer by screening using the immunochemical faecal occult blood test: a case-control study. Br J Cancer 2003;89:23-8.
16. Lee KJ, Inoue M, Otani T et al. Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: a prospective cohort study in Japan. Cancer Detect Prev 2007;31:3-11.
17. Zappa M, Castiglione G, Grazzini G et al. Effect of faecal occult blood testing on colorectal mortality: results of a population-based case-control study in the district of Florence, Italy. Int J Cancer 1997;73:208-10.
18. van Rossum LG, van Rijn AF, Laheij RJ et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008;135:82-90.
19. Hol L, van Leerdam ME, van Ballegooijen M et al. Attendance to screening for colorectal cancer in the Netherlands; randomized controlled trial comparing two different forms of faecal occult blood tests and sigmoidoscopy. Gastroenterology 2008;134:A87.
20. Agrawal S, Bhupinderjit A, Bhutani MS et al. Colorectal cancer in African Americans. Am J Gastroenterol 2005;100:515-23; discussion 514.
21. Cuh KC, Tarone RE, Chow WH et al. Temporal patterns in colorectal cancer incidence, survival, and mortality from 1950 through 1990. J Natl Cancer Inst 1994;86:997-1006.
22. Schoenfeld P, Cash B, Flood A et al. Colonoscopic screening of average-risk women for colorectal neoplasia. N Engl J Med 2005;352:2061-8.
23. Lieberman DA, Weiss DG, Bond JH et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 2000;343:162-8.
24. Regula J, Rupinski M, Kraszewska E et al. Colonoscopy in colorectalcancer screening for detection of advanced neoplasia. N Engl J Med 2006;355:1863-72.
25. Rex D, Sledge G, Harper P et al. Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: influence of age, gender, and family history. Am J Gastroenterol 1993;88:825-31.
26. Cottet V, Pariente A, Nalet B et al. Colonoscopic screening of, first-degree relatives of patients with large adenomas: increased risk of colorectal tumors. Gastroenterology 2007;133:1086-92.
27. Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 1992;326:658-62.
28. Rex DK, Helbig CC. High yields of small and flat adenomas with high-definition colonoscopes using either white light or narrow band imaging. Gastroenterology 2007;133:42-7.
29. Vasen HF, Moslein G, Alonso A et al. Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 2008;57:704-13.
30. Umar A, Boland CR, Terdiman PJ et al. Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004;96:261-8.
31. Giovannucci E. An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2001;10:725-31.
32. Driver JA, Gaziano JM, Gelber RP et al. Development of a risk score for colorectal cancer in men. Am J Med 2007;120:257-63.
33. Centers for Disease Control and Prevention (CDC). Cigarette smoking among adults-United States, 2006. MMWR Morb Mortal Wkly Rep 2007;56:1157-61.
34. Giovannucci E, Colditz GA, Stampfer MJ et al. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. women. J Natl Ca ncer Inst 1994;86:192-9.
35. Giovannucci E, Rimm EB, Stampfer MJ et al. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. men. J Natl Cancer Inst 1994;86:183-19.
36. Heineman EF, Zahm SH, McLaughlin JK et al. Increased risk of colorectal cancer among smokers: results of a 26-year follow-up of US veterans and a review. Int J Cancer 1994;59:728-38.
37. Newcomb PA, Storer BE, Marcus PM. Cigarette smoking in relation to risk of large bowel cancer in women. Cancer Res 1995;55:4906-9.
38. Paskett ED, Reeves KW, Rohan TE et al. Association between cigarette smoking and colorectal cancer in the Women's Health Initiative. J Natl Cancer Inst 2007;99:1729-35.
39. Slattery ML, Potter JD, Friedman GD et al. Tobacco use and colon cancer. Int J Cancer 1997;70:259-64.
40. Sturmer T, Glynn RJ, Lee IM et al. Lifetime cigarette smoking and colorectal cancer incidence in the Physicians' Health Study I. J Natl Cancer Inst 2000;92:1178-81.
41. Terry P, Ekbom A, Lichtenstein P et al. Long-term tobacco smoking and colorectal cancer in a prospective cohort study. Int J Cancer 2001;91:585-7.
42. Caho A, Thun MJ, Jacobs EJ et al. Cigarette smoking and colorectal cancer mortality in the cancer prevention study II. J Natl Cancer Inst 2000;92:1888-96.
43. Colangelo LA, Gapstur MS, Gann PH et al. Cigarette smoking and colorectal carcinoma mortality in a cohort with long-term follow-up. Cancer 2004;100:288-93.
44. Messina CR, Kabat GC, Lane DS. Perceptions of risk factors for breast cancer and attitudes toward mammography among women who are current, ex- and non-smokers. Women Health 2002;36:65-82.
45. Buc E, Kwiatkowski F, Alves A et al. Tobacco smoking: a factor of early onset of colorectal cancer. Dis Colon Rectum 2006;49:1893-6.
46. Michalek AM, Cummings KM. The association between cigarette smoking and age at cancer diagnosis. Hum Biol 1987;59:631-9.
47. Zisman AL, Nickolov A, Brand RE et al. Associations between the age at diagnosis and location of colorectal cancer and the use of alcohol and tobacco: implications for screening. Arch Intern Med 2006;166:629-34.
48. Campbell RJ, Ferrante MJ, Gonzalez EC et al. Predictors of advanced stage colorectal cancer diagnosis: results of a population-based study. Cancer Detect Prev 2001;25:430-8.
49. Anderson CJ, Attam R, Alpern Z et al. Prevalence of colorectal neoplasia in smokers. Am J Gastroenterol 2003;98:2777-83.
50. Lieberman DA, Prindiville S, Weiss DG et al. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA 2003;290:2959-67.
51. Limburg PJ, Vierkant RA, Cerhan RJ et al. Cigarette smoking and colorectal cancer: long-term, subsite-specific risks in a cohort study of postmenopausal women. Clin Gastroenterol Hepatol 2003;1:202-10.
52. Slattery ML, Curtin K, Anderson K et al. Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst 2000;92:1831-6.
53. Anderson CJ, Alpern Z, Messina CR et al. Predictors of proximal neoplasia in patients without distal adenomatous pathology. Am J Gastroenterol 2004;99:472-7.
54. Martinez ME, Reid M, Jiang R et al. Accuracy of self-reported smoking status among participants in a chemoprevention trial. Prev Med 2004;38:492-7.
55. Adams KF, Leitzmann MF, Albanes D et al. Body mass and colorectal cancer risk in the NIH-AARP cohort. Am J Epidemiol 2007;166:36-45.
56. Larsson SC, Wolk A. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr 2007;86:556-65.
57. Anderson CJ, Messina CR, Dakhllalah F et al. Body mass index: a marker for significant colorectal neoplasia in a screening population. J Clin Gastroenterol 2007;41:285-90.
58. Dai Z, Xu YC, Niu L. Obesity and colorectal cancer risk: a meta-analysis of cohort studies. World J Gastroenterol 2007;13:4199-206.
59. Bergstrom A, Pisani P, Tenet V et al. Overweight as an avoidable cause of cancer in Europe. Int J Cancer 2001;91:421-30.
60. Gunter MJ, Leitzmann MF. Obesity and colorectal cancer: epidemiology, mechanisms and candidate genes. J Nutr Biochem 2006;17:145-56.
61. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 2001;131:3109S-20S.
62. Bird CL, Frankl HD, Lee ER et al. Obesity, weight gain, large weight changes, and adenomatous polyps of the left colon and rectum. Am J Epidemiol 1998;147:670-80.
63. Shinchi K, Kono S, Honjo S et al. Obesity and adenomatous polyps of the sigmoid colon. Jpn J Cancer Res 1994;85:479-84.
64. Neugut AI, Lee WC, Garbowski GC et al. Obesity and colorectal adenomatous polyps. J Natl Cancer Inst 1991;83:359-61.
65. John BJ, Irukulla S, Abula, AM et al. Systematic review: adipose tissue, obesity and gastrointestinal diseases. Aliment Pharmacol Ther 2006;23:1511-23.
66. Rondinone CM. Adipocyte-derived hormones, cytokines, and mediators. Endocrine 2006;29:81-90.
67. Trayhurn P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 2001;60:329-39.
68. Amemor S, Ootani A, Fujise T et al. Adipocytes and preadipocytes promote the proliferation of colon cancer cells in vitro. Am J Physiol Gastrointest Liver Physiol 2007;292:G923-9.
69. Hoda MR, Keely SJ, Bertelsen LS et al. Leptin acts as a mitogenic and antiapoptotic factor for colonic cancer cells. Br J Surg 2007;94:346-54.
70. El-Serag HB. Esophagus and colon disease. Gastroenterol Clin North Am. In: Johnson DA (ed). Obesity and the Gastroenterologist. 2005;34:63-82.
71. Thiis-Evensen E, Hoff G, Sauar J et al. Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand J Gastroenterol 1999;34:414-20.
72. Mandel JS, Church TR, Bond HJ et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603-7.
73. Winawer SJ, Zauber AG, Ho MN et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993;329:1977-81.
74. Citarda F, Tomaselli G, Capocaccia R et al. The Italian Multicentre Study Group. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut 2001;48:812-5.
75. Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann Intern Med 1995;123:904-10.
76. Brenner H, Chang-Claude J, Seiler CM et al. Does a negative screening colonoscopy ever need to be repeated? Gut 2006;55:1145-50.
77. Gross CP, Andersen MS, Krumholz HM et al. Relation between Medicare screening reimbursement and stage at diagnosis for older patients with colon cancer. JAMA 2006;296:2815-22.
78. Sedjo RL, Byers T, Barrera E Jr et al. A midpoint assessment of the American Cancer Society challenge goal to decrease cancer incidence by 25% between 1992 and 2015. CA Cancer J Clin 2007;57:326-40.
79. Selby VJ, Friedman GD, Quesenberry CP Jr et al. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653-7.
80. Newcomb PA, Storer BE, Morimoto LM et al. Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence. J Natl Cancer Inst 2003;95:622-5.
81. Seeff LC, Manninen DL, Dong FB et al. Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States? Gastroenterology 2004;127:1661-9.
82. Rex DK, Chak A, Vasudeva R et al. Prospective determination of distal colon findings in average-risk patients with proximal colon cancer. Gastrointest Endosc 1999;49:727-30.
83. Jass JR. Hyperplastic polyps and colorectal cancer: is there a link? Clin Gastroenterol Hepatol 2004;2:1-8.
84. Leard LE, Savides TJ, Ganiats TG. Patient preferences for colorectal cancer screening. J Fam Pract 1997;45:211-8.
85. Zubarik R, Ganguly E, Benway D et al. Procedure-related abdominal discomfort in patients undergoing colorectal cancer screening: a comparison of colonoscopy and flexible sigmoidoscopy. Am J Gastroenterol 2002;97:3056-61.
86. Gatto NM, Frucht H, Sundararajan V et al. Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. J Natl Cancer Inst 2003;95:230-6.
87. Levin TR, Zhao W, Conell C et al. C omplications of colonoscopy in an integrated health care delivery system. Ann Intern Med 2006;145:880-6.
88. Rex DK, Petrini JL, Baron TH et al. Quality indicators for colonoscopy. Am J Gastroenterol 2006;101:873-85.
89. Rex DK. Have we defined best colonoscopic polypectomy practice in the United States? Clin Gastroenterol Hepatol 2007;5:674-7.
90. Pabby A, Schoen RE, Weissfeld JL et al. Analysis of colorectal cancer occurrence during surveillance colonoscopy in the dietary Polyp Prevention Trial. Gastrointest Endosc 2005;61:385-91.
91. Farrar WD, Sawhney MS, Nelson DB et al. Colorectal cancers found after a complete colonoscopy. Clin Gastroenterol Hepatol 2006;4:1259-64.
92. Lieberman DA, Weiss DG, Harford WV et al. Five-year colon surveillance after screening colonoscopy. Gastroenterology 2007;133:1077-85.
93. Rex DK, Cummings OW, Helper DJ et al. 5-year incidence of adenomas after negative colonoscopy in asymptomatic average-risk persons [see comment]. Gastroenterology 1996;111:1178-81.
94. Avidan B, Sonnenberg A, Schnell TG et al. New occurrence and recurrence of neoplasms within 5 years of a screening colonoscopy. Am J Gastroenterol 2002;97:1524-9.
95. Imperiale TF, Glowinski EA, Lin-Cooper C et al. Five-year risk of colorectal neoplasia after negative screening colonoscopy. N Engl J Med 2008;359:1218-24.
96. Burke CA, Elder K, Lopez R. Screening for colorectal cancer with flexible sigmoidoscopy: is a 5-yr interval appropriate? A comparison of the detection of neoplasia 3 yr vs. 5 yr after a normal examination. Am J Gastroenterol 2006;101:1329-32.
97. Schoen RE, Pinsky PF, Weissfeld JL et al. Results of repeat sigmoidoscopy 3 years after a negative examination. JAMA 2003;290:41-8.
98. Singh H, Turner D, Xue L et al. Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. JAMA 2006;295:2366-73.
99. Singh G, Gerson LB, Wang H et al. Screening colonoscopy, colorectal cancer and gender: an unfair deal for the fair sex? Gastrointest Endosc 2007;65:AB100.
100. Sawhney MS, Farrar WD, Gudiseva S et al. Microsatellite instability in interval colon cancers. Gastroenterology 2006;131:1700-5.
101. Arain M, Sheikh S, Thaygarajan B et al. Molecular markers of rapidly growing tumors: another piece to the puzzle. Am J Gastroenterol 2008;103:S200.
102. Rex DK, Bond JH, Winawer S et al. Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol 2002;97:1296-308.
103. Rex DK. Maximizing detection of adenomas and cancers during colonoscopy. Am J Gastroenterol 2006;101:2866-77.
104. Barclay RL, Vicari JJ, Doughty AS et al. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med 2006;355:2533-41.
105. Chen SC, Rex DK E.ndoscopist can be more powerful than age and male gender in predicting adenoma detection at colonoscopy. Am J Gastroenterol 2007;102:856-61.
106. Rex DK, Rahmani EY, Haseman JH et al. Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. Gastroenterology 1997;112:17-23.
107. Bressler B, Paszat LF, Chen Z et al. Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology 2007;132:96-102.
108. Singh H, Turner D, Xue L et al. Colorectal cancers after a negative colonoscopy. Gastroenterology 2007;132:A149.
109. Alberts DS, Martinez ME, Roe DJ et al. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network. N Engl J Med 2000;342:1156-62.
110. Schatzkin A, Lanza E, Corle D et al. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. N Engl J Med 2000;342:1149-55.
111. Robertson DJ, Greenberg ER, Beach M et al. Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology 2005;129:34-41.
112. Harewood GC, Sharma VK, de Garmo P. Impact of colonoscopy preparation quality on detection of suspected colonic neoplasia. Gastrointest Endosc 2003;58:76-9.
113. Froehlich F, Wietlisbach V, Gonvers JJ et al. Impact of colonic cleansing on quality and diagnostic yield of colonoscopy: the European Panel of Appropriateness of Gastrointestinal Endoscopy European multicenter study. Gastrointest Endosc 2005;61:378-84.
114. Jain S, Johnson WD, Minocha A. Impact of quality of bowel preparation on the detection of colonic polyps during colonoscopy: a prospective study. Gastroenterology 2007;132:A315.
115. Cohen L, Kastenberg D, Lottes RS et al. Polyp detection rate during colonoscopy is correlated with quality of bowel preparation. Am J Gastroenterol 2006;101:S556.
116. Parra-Blanco A, Nicolas-Perez D, Gimeno-Garcia A et al. The timing of bowel preparation before colonoscopy determines the quality of cleansing, and is a significant factor contributing to the detection of flat lesions: a randomized study. World J Gastroenterol 2006;12:6161-6.
117. Rostom A, Jolicoeur E, Dube C et al. A randomized prospective trial comparing different regimens of oral sodium phosphate and polyethylene glycol-based lavage solution in the preparation of patients for colonoscopy. Gastrointest Endosc 2006;64:544-52.
118. Aoun E, Abdul-Baki H, Azar C et al. A randomized single-blind trial of split-dose PEG-electrolyte solution without dietary restriction compared with whole dose PEG-electrolyte solution with dietary restriction for colonoscopy preparation. Gastrointest Endosc 2005;62:213-8.
119. Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration: application to healthy patients undergoing elective procedures: a report by the American Society of Anesthesiologist Task Force on Preoperative Fasting. Anesthesiology 1999;90:896-905.
120. Wexner SD, Beck DE, Baron TH et al. A consensus document on bowel preparation before colonoscopy: prepared by a Task Force from the American Society of Colon and Rectal Surgeons (ASCRS), the American Society for Gastrointestinal Endoscopy (ASGE), and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Surg Endosc 2006;20:1161.
121. Rockey DC, Paulson E, Niedzwiecki D et al. Analysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: prospective comparison. Lancet 2005;365:305-11.
122. Johnson CD, MacCarty RL, Welch TJ et al. Comparison of the relative sensitivity of CT colonography and double-contrast barium enema for screen detection of colorectal polyps. Clin Gastroenterol Hepatol 2004;2:314-21.
123. Johnson CD, Chen MH, Toledano AY et al. Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med 2008;359:1207-17.
124. Pickhardt P, Choi J, Hwang I. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 2003;349:2191-200.
125. Johnson CD, Harmsen WS, Wilson LA et al. Prospective blinded evaluation of computed tomographic colonography for screen detection of colorectal polyps. Gastroenterology 2003;125:311-9.
126. Rex DK, Lieberman D. ACG colorectal cancer prevention action plan: update on CT-colonography. Am J Gastroenterol 2006;101:1410-3.
127. Brenner DJ, Georgsson MA. Mass screening with CT colonography: should the radiation exposure be of concern? Gastroenterology 2005;129:328-37.
128. Brenner DJ, Hall EJ. Computed tomography - an increasing source of radiation exposure. N Engl J Med 2007;357:2277-84.
129. Hur C, Chung DC, Schoen RE et al. The management of small polyps found by virtual colonoscopy: results of a decision analysis. Clin Gastroenterol Hepatol 2007;5:237-44.
130. Imperiale TF, Ransohoff DF, Itzkowitz SH et al. Fecal DNA vs. fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004;351:2704-14.
131. Ahlquist D, Sargent DJ, Levin TR et al. Stool DNA screening for colorectal cancer: prospective multicenter comparison with hemoccult. Gastroenterology 2005;128:A63.
132. Whitney D, Skoletsky J, Moore K et al. Enhanced retrieval of DNA from human fecal samples results in improved performance of colorectal cancer screening test. J Mol Diagn 2004;6:386-95.
133. Itzkowitz SH, Jandorf L, Brand R et al. Improved fecal DNA test for colorectal cancer screening. Clin Gastroenterol Hepatol 2007;5:111-7.